Dec 19, 2017
Inflammatix announced today that it has appointed Oliver Liesenfeld as chief medical officer. Liesenfeld comes to Inflammatix from Roche Diagnostics, where he has served as chief medical officer since 2012. Liesenfeld has over 25 years of industry and academic experience in the diagnostics field, with a focus on molecular diagnostics and infectious disease. Prior to Roche, Liesenfeld served as associate professor of medical microbioilogy and infection immunology at the Charite Medical School in Berlin, Germany, where his research focused on immune response to infections.